PositiveID (PositiveID) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2018)

View and export this data going back to 2007. Start your Free Trial

What is PositiveID LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PositiveID's long-term debt to total assests ratio for the quarter that ended in Mar. 2018 was 0.00.

PositiveID's long-term debt to total assets ratio declined from Mar. 2017 (0.01) to Mar. 2018 (0.00). It may suggest that PositiveID is progressively becoming less dependent on debt to grow their business.

PositiveID LT-Debt-to-Total-Asset Historical Data

The historical data trend for PositiveID's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PositiveID LT-Debt-to-Total-Asset Chart

PositiveID Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

PositiveID Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	-	-	0.01	-

PositiveID LT-Debt-to-Total-Asset Calculation

PositiveID's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2017 is calculated as

LT Debt to Total Assets (A: Dec. 2017 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2017 )	/	Total Assets (A: Dec. 2017 )
	=	0.008	/	1.725
	=	0.00

PositiveID's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2018 is calculated as

LT Debt to Total Assets (Q: Mar. 2018 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2018 )	/	Total Assets (Q: Mar. 2018 )
	=	0	/	1.213
	=	0.00

PositiveID (OTCPK:PSID) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PositiveID LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PositiveID's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PositiveID (PositiveID) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PositiveID Corp (OTCPK:PSID) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1690 South Congress Avenue, Suite 201, Delray Beach, FL, USA, 33445

Website

http://www.psidcorp.com

PositiveID Corp is a life science tools and diagnostics company. It specializes in the biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. The business activity of the firm includes the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its subsidiary. Further, it is also involved in the development of FireflyDX family of products, automated pathogen detection system for rapid diagnostics, both for clinical and point-of-need applications. In addition, it also manufactures specialty technology vehicles focused primarily on mobile laboratory and communications applications. All the activities are carried out through the US.

Executives

Ned L Siegel	director	600 WILSHIRE BOULEVARD, LOS ANGELES CA 90017
Michael E Krawitz	director	1690 S CONGRESS AVE, STE 201, DELRAY BEACH FL 33445
Barry M Edelstein	director	1100 GREEN VALLEY ROAD, BRYN MAWR PA 19010
Scott R Silverman	other: Former 10% Owner
Marxe Austin W & Greenhouse David M	10 percent owner	C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Weaver Constance K	director	2900 ESPERANZA CROSSING, 2ND FLOOR, AUSTIN TX 78758
Tommy G Thompson	director	7711 CARONDELET, ST. LOUIS MO 63105